1,455
Participants
Start Date
November 30, 2003
Primary Completion Date
November 30, 2007
Study Completion Date
November 30, 2007
xaliproden (SR57746A)
The Clinical Trial Center, Jenkintown
The Innovative Clinical Research Center, Alexandria
National Clinical Research, Inc, Richmond
"Eastern Virginia Medical School - The Glennan Center For Geriatrics Gerontology", Norfolk
Alzheimer's Research & Clinical Programs, North Charleston
Radiant Research, Greer
CNS Healthcare, Jacksonville
Mayo Clinic, Jacksonville
Memory Disorder Center, Pompano Beach
Renstar Medical Research, Ocala
Harmony Research, Inc, Johnson City
University Medical Center, Dept. of Psychiatry Clinical Trials, Jackson
Lexington Clinic, Lexington
Hartford Research Group, Florence
The Ohio State University, Columbus
Neurological Center, Fort Wayne
Synergy Medical, Saginaw
Radiant Research, Inc., St Louis
Vince and Associates Clinical Research, Overland Park
LSUHSC Geriatric Psychiatry, New Orleans
Grayline Clinical Drug Trial, Wichita Falls
R/D Clinical Research, Inc., Lake Jackson
Neurological Physicians of Arizona, Inc., Mesa
Pivotal Research Centers, Mesa
Pivotal Research Centers, Peoria
Optimum Health Services, Oceanside
Anderson Clinical Research, Redlands
Northwest NeuroSpecialists, Tucson
Univ. of CT Health Center, Farmington
Brigham and Women's Hospital, Boston
Center For Emotional Fitness, Moorestown
Ubhc/Umdnj667, Piscataway
sanofi-aventis Australia & New Zealand administrative office, Macquarie Park, New South Wales
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Causeway Bay
Sanfoi-Aventis Administrative Office, Milan
Sanofi-Aventis Administrative Office, Gouda
Sanofi-Aventis Administrative Office, Singapore
Sanofi-Aventis Administrative Office, Midrand
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Taipei
Lead Sponsor
Sanofi
INDUSTRY